No Data
Realcan Pharmaceutical Group (002589.SZ): A total of 0.7% of shares have been repurchased.
On March 4, Gelonghui reported that Realcan Pharmaceutical Group (002589.SZ) announced that as of February 28, 2025, the company repurchased 10.51155 million shares through a dedicated securities account for share buybacks via centralized bidding, accounting for 0.70% of the company's total share capital. The highest Fill Price was 3.08 yuan/share, the lowest Fill Price was 2.93 yuan/share, and the total amount of the transaction was 31.653535 million yuan (excluding transaction fees). This share repurchase complies with the company's established share buyback plan and relevant laws and regulations.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Realcan Pharmaceutical to Buy Majority Stake in First-Class Medical Device Maker for 151 Million Yuan
Realcan Pharmaceutical Group (002589.SZ): First repurchase of 4.2918 million shares involving a capital of 12.7583 million yuan.
Glonghui reported on February 14 that Realcan Pharmaceutical Group (002589.SZ) announced that on February 14, 2025, the company first repurchased shares through a dedicated securities account for Share Buyback in a centralized bidding manner, with the number of repurchased shares being 4.29183 million shares, accounting for 0.29% of the company's total equity. Among these, the highest Fill Price was 2.99 yuan/share, the lowest Fill Price was 2.93 yuan/share, and the total amount of the transaction was 12.7583 million yuan (excluding trading fees).
Realcan Pharmaceutical Group (002589.SZ): Share repurchase has not yet been implemented.
Gelonghui January 9丨 Realcan Pharmaceutical Group (002589.SZ) announced that as of December 31, 2024, the company has not yet implemented a share buyback.
Realcan Pharmaceutical Group (SZSE:002589) Stock Falls 10% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
Benign Growth For Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Underpins Stock's 30% Plummet
